3-Phenylpyridine
3-Phenylpyridine structure
|
Common Name | 3-Phenylpyridine | ||
|---|---|---|---|---|
| CAS Number | 1008-88-4 | Molecular Weight | 155.196 | |
| Density | 1.0±0.1 g/cm3 | Boiling Point | 273.5±0.0 °C at 760 mmHg | |
| Molecular Formula | C11H9N | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | 119.3±11.4 °C | |
| Symbol |
GHS07 |
Signal Word | Warning | |
|
Raman excitation profiles and excited state molecular configurations of three isomeric phenyl pyridines.
Spectrochim. Acta. A. Mol. Biomol. Spectrosc. 56(5) , 855-75, (2000) Contributions of different electronic states to Raman scattering have been studied by critical analyses of Raman excitation profiles (REPs) of several normal modes of vibration of three isomeric phenyl pyridines. In this context, possible structures and other... |
|
|
Surface-enhanced Raman spectroscopy studies of phenylpyridines interacting with a copper electrode surface. Zawada K and Bukowska J.
Surface Science 507 , 34-9, (2002)
|
|
|
Oxygenation of hydrocarbons by cytochrome P-450 model compounds: modification of reactivity by axial ligands.
Proc. Natl. Acad. Sci. U. S. A. 80(22) , 7039-41, (1983) The rate of olefin oxygenation catalyzed by synthetic metalloporphyrins is examined, employing sodium hypochlorite as the oxygen atom source. The rate of epoxidation and the stability of the catalyst are shown to be dependent on the nature of the axial ligand... |
|
|
1H, 13C and 15N nuclear magnetic resonance coordination shifts in Au(III), Pd(II) and Pt(II) chloride complexes with phenylpyridines.
Magn. Reson. Chem. 47(8) , 658-65, (2009) 1H, 13C and 15N nuclear magnetic resonance studies of gold(III), palladium(II) and platinum(II) chloride complexes with phenylpyridines (PPY: 4-phenylpyridine, 4ppy; 3-phenylpyridine, 3ppy; and 2-phenylpyridine, 2ppy) having the general formulae [Au(PPY)Cl3],... |
|
|
Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase.
J. Med. Chem. 51 , 4968-77, (2008) Indoleamine 2,3-dioxygenase (IDO) is emerging as an important new therapeutic target for the treatment of cancer, chronic viral infections, and other diseases characterized by pathological immune suppression. With the goal of developing more potent IDO inhibi... |
|
|
SCH 530348: a novel oral thrombin receptor antagonist.
Future Cardiol. 5(5) , 435-42, (2009) SCH 530348, a synthetic tricyclic 3-phenylpyridine, is an orally active fourth generation himbacine-based antagonist of the protease-activated receptor (PAR)-1, the primary receptor for thrombin on platelets in humans. SCH 530348 is the first in a new class o... |
|
|
2-Phenylpyridine and 3-phenylpyridine, constituents of tea, are unlikely to cause idiopathic Parkinson's disease.
J. Neurol. Sci. 85(3) , 309-17, (1988) Idiopathic Parkinson's disease (PD) is likely to be caused by one or more unidentified neurotoxins, present in the environment or formed endogenously, which progressively damage dopaminergic nigrostriatal neurons. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine ... |